Our findings suggested that protective effects against recurrent kidney stones were afforded by urokinase-ApaLI (recessive model), VDR-ApaI (dominant model), and VDR-TaqI (heterozygous model) gene polymorphisms. Here, VDR is linked to nephrolithiasis.